company background image
MDT logo

Medtronic NYSE:MDT Stock Report

Last Price

US$85.71

Market Cap

US$111.0b

7D

0.03%

1Y

8.7%

Updated

03 Dec, 2024

Data

Company Financials +

Medtronic plc

NYSE:MDT Stock Report

Market Cap: US$111.0b

MDT Stock Overview

Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. More details

MDT fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance3/6
Financial Health3/6
Dividends5/6

Rewards

Trading at 35.6% below our estimate of its fair value

Earnings are forecast to grow 10.19% per year

Pays a reliable dividend of 3.27%

Trading at good value compared to peers and industry

Risk Analysis

Has a high level of debt


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 28 Analysts

Innovative Medical Technologies Drive Dynamic Growth And Strengthen Market Position

Key Takeaways Strong innovation in high-impact markets and disciplined cost management are driving consistent earnings and revenue growth. Strategic investments and technological advancements in segments like robotics and diabetes are expected to enhance competitive advantage and future growth.
View narrative
US$96.43
FV
11.1% undervalued intrinsic discount
4.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
6 days ago author updated this narrative

Medtronic plc Competitors

Boston Scientific

NYSE:BSX

US$133.3b

Stryker

NYSE:SYK

US$148.5b

Becton Dickinson

NYSE:BDX

US$64.4b

Abbott Laboratories

NYSE:ABT

US$202.6b

Price History & Performance

Summary of all time highs, changes and price drops for Medtronic
Historical stock prices
Current Share PriceUS$85.71
52 Week HighUS$92.68
52 Week LowUS$75.96
Beta0.83
11 Month Change-4.84%
3 Month Change-5.84%
1 Year Change8.74%
33 Year Change-23.66%
5 Year Change-22.81%
Change since IPO58,804.38%

Recent News & Updates

Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Dec 03
Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Recent updates

Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Dec 03
Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Oct 31

Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Oct 13
Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Medtronic: Undervalued Dividend Aristocrat With High Margins

Oct 10

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Sep 30
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Sep 16
Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Sep 16

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Sep 05
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Is The Company Back?

Aug 26

Medtronic: Still A Buy Before Earnings

Aug 17

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Aug 08
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential

Jul 16

At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Jul 11
At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Jun 27
Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Medtronic: Why I Disagree With The Crowd

Jun 14

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

May 27

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

May 26
Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

May 22
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

May 13

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

May 01
Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Shareholder Returns

MDTUS Medical EquipmentUS Market
7D0.03%-0.03%0.4%
1Y8.7%21.3%32.3%

Return vs Industry: MDT underperformed the US Medical Equipment industry which returned 21.3% over the past year.

Return vs Market: MDT underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is MDT's price volatile compared to industry and market?
MDT volatility
MDT Average Weekly Movement2.4%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.3%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: MDT has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: MDT's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194995,000Geoff Marthawww.medtronic.com

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.

Medtronic plc Fundamentals Summary

How do Medtronic's earnings and revenue compare to its market cap?
MDT fundamental statistics
Market capUS$110.97b
Earnings (TTM)US$4.29b
Revenue (TTM)US$33.00b

25.6x

P/E Ratio

3.3x

P/S Ratio

Is MDT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDT income statement (TTM)
RevenueUS$33.00b
Cost of RevenueUS$11.42b
Gross ProfitUS$21.58b
Other ExpensesUS$17.29b
EarningsUS$4.29b

Last Reported Earnings

Oct 25, 2024

Next Earnings Date

Feb 18, 2025

Earnings per share (EPS)3.34
Gross Margin65.40%
Net Profit Margin13.00%
Debt/Equity Ratio58.0%

How did MDT perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

85%

Payout Ratio